Silexion, a Clinical-Stage, Oncology-Focused Biotechnology Company, to Become Publicly Traded Via Business Combination with Moringa Acquisition Corp
Acquiring Company
Moringa Acquisition
Acquired Company
Silexion Therapeutics
New York
IsraelBiotechnologyHealth CareTherapeuticsPharmaceuticalDescription
Moringa Acquisition Corp (Nasdaq: MACA), a special purpose acquisition company, has entered into a business combination agreement with Silexion Ltd., a clinical-stage, oncology-focused biotechnology company. This agreement will result in Silexion becoming publicly listed on the Nasdaq. The business combination provides for Silexion’s pre-transaction equity value to be $62.5 million, based on a $10 share price. The proposed merger with Silexion is expected to provide the opportunity for both respective shareholders to participate in the potential of Silexion’s powerful platform as a public company listed on Nasdaq.
Quick answer
Moringa Acquisition is acquiring Silexion Therapeutics, announced February 22, 2024. Moringa Acquisition is based in New York, New York, United States.
- How much did Moringa Acquisition pay for Silexion Therapeutics?
- The deal value was not disclosed.
- What does Moringa Acquisition do?
- Moringa Acquisition Corp (Nasdaq: MACA) is a publicly-listed special purpose acquisition company.
- Where are Moringa Acquisition and Silexion Therapeutics based?
- Moringa Acquisition is based in New York, New York, United States. Silexion Therapeutics is based in Israel.
Source: Fundz verified event record.
Who to call at Moringa Acquisition, and when
When Moringa Acquisition changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Moringa Acquisition raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Moringa Acquisition, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Moringa Acquisition. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Moringa Acquisition makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Silexion Therapeutics?
Silexion Therapeutics was acquired by Moringa Acquisition, based in New York. The deal was reported on February 22, 2024. Moringa Acquisition Corp (Nasdaq: MACA) is a publicly-listed special purpose acquisition company. Moringa Acquisition is privately held.
When did Moringa Acquisition acquire Silexion Therapeutics?
Moringa Acquisition's acquisition of Silexion Therapeutics was reported on February 22, 2024. Moringa Acquisition Corp (Nasdaq: MACA), a special purpose acquisition company, has entered into a business combination agreement with Silexion Ltd., a clinical-stage, oncology-focused biotechnology company. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Silexion Therapeutics do?
Silexion Therapeutics Ltd. It is publicly traded (SLXN), operating in Biotechnology, and is based in Israel.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.